WallStreetZenWallStreetZen

NASDAQ: AMRN
Amarin Corp PLC Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

AMRN past revenue growth

How has AMRN's revenue growth performed historically?
Company
-16.87%
Industry
4.53%
Market
17.15%
AMRN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AMRN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AMRN's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

AMRN earnings and revenue history

Current Revenue
$306.9M
Current Earnings
-$59.1M
Current Profit Margin
-19.3%

AMRN Return on Equity

Current Company
-10.5%
Current Industry
34.1%
Current Market
188%
AMRN's Return on Equity (-10.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when AMRN announces earnings.

AMRN Return on Assets

Current Company
-7%
Current Industry
8.3%
AMRN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

AMRN Return on Capital Employed

Current Company
-9.37%
Current Industry
14.8%
AMRN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

AMRN vs General Drug Manufacturer Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
AMRN$306.91M-$50.70M-$59.11M+6.01%N/A
SCLX$46.74M-$108.60M-$114.33M+22.10%N/A
GRFS$7.09B$1.23B$63.78M+7.27%-36.90%
OGN$6.26B$1.44B$1.02B-8.52%-25.02%
BIIB$9.84B$1.79B$1.16B-6.07%-18.00%
View Top General Drug Manufacturer Stocks

AMRN earnings dates

Next earnings date
May 1, 2024

Amarin Earnings & Revenue FAQ

What were AMRN's earnings last quarter?

On Invalid Date, Amarin (NASDAQ: AMRN) reported Q4 2023 earnings per share (EPS) of -$0.02, up 300% year over year. Total Amarin earnings for the quarter were -$5.78 million. In the same quarter last year, Amarin's earnings per share (EPS) was $0.01.

If you're new to stock investing, here's how to buy Amarin stock.

What was AMRN's earnings growth in the past year?

As of Q2 2024, Amarin's earnings has grown year over year. Amarin's earnings in the past year totalled -$59.11 million.

What is AMRN's earnings date?

Amarin's earnings date is Invalid Date. Add AMRN to your watchlist to be reminded of AMRN's next earnings announcement.

What was AMRN's revenue last quarter?

On Invalid Date, Amarin (NASDAQ: AMRN) reported Q4 2023 revenue of $74.71 million up 17.21% year over year. In the same quarter last year, Amarin's revenue was $90.25 million.

What was AMRN's revenue growth in the past year?

As of Q2 2024, Amarin's revenue has grown -16.87% year over year. This is 21.4 percentage points lower than the US Drug Manufacturers - General industry revenue growth rate of 4.53%. Amarin's revenue in the past year totalled $306.91 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.